Concepedia

Phammela Abarzua

PA

Statistics

Publications

5

Citations

114

H-Index

5

Active since

2019

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Massachusetts General Hospital

VA Boston Healthcare System

University Medical Center Freiburg

Phammela Abarzua is an author at Brigham and Women's Hospital specializing in life sciences, molecular immunology, and molecular biology.

ORCID

Publications per year

2019–2023

5

Publications

5

Loss of the Epigenetic Mark 5-hmC in Psoriasis: Implications for Epidermal Stem Cell Dysregulation

Li Feng, Christine Wan-Yin Yuan, Shuyun Xu et al. · Journal of Investigative Dermatology · 2019 · 28 citations · Full text

, , +13

ATF-3 expression inhibits melanoma growth by downregulating ERK and AKT pathways

Tingjian Zu, Diana Wang, Shuyun Xu et al. · Laboratory Investigation · 2020 · 28 citations · Full text

, , +14

Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor 𝛋B kinase alpha (IKKα)

Wayne Bainter, Vassilios Lougaris, Jacqueline G. Wallace et al. · Science Immunology · 2021 · 23 citations · Full text

, , +16

T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation

Thiago J. Borges, Phammela Abarzua, Rodrigo Benedetti Gassen et al. · Cell Reports Medicine · 2022 · 18 citations · Full text

, , +17

Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study

Naoka Murakami, Thiago J. Borges, Thet Su Win et al. · American Journal of Transplantation · 2023 · 17 citations · Full text

, , +14

1–5 of 5